🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

SCWO SCWO

Company Profile ↓
$2.26
+18.68% 1Y
Mkt Cap$38.74M
P/E-1.64
P/B5.76
52W High$7.00
52W Low$1.76
Book Value$0.39
EPS (TTM)$-1.38

Company Overview

SCWO (SCWO) is a publicly traded company listed on with a market capitalization of $38.74M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 14.1% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.18.

Recent Developments

  • Dec 2025 Revenue of $215.04K (-51.7% YoY); net profit $-20.98M.
  • Trailing 12 Months Year-on-year growth — revenue -51.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 14.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:14.12%
1 Year:-51.73%

Stock Price Performance

1 Year:+18.68%
6 Months:-24.83%
3 Months:+1.58%
1 Month:+13.32%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 10% of range
$1.76 $7.00
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)54.48 · Neutral
Price Performance
1M+13.32%
3M+1.58%
6M-24.83%
1Y+18.68%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 14.1% over 5 years.

CONS

  • Trading 67.8% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-1.64
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$0.39
Price to Book
5.76
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
14.12%
Profit 5Y
-
Revenue (YoY)
-51.73%
Earnings (YoY)
-

Profitability & Returns

ROCE
-
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.26
EPS (TTM)
$-1.38

Balance Sheet & Liquidity

Debt/Equity
0.18
Quick Ratio
1.05
Current Ratio
1.40
Debt
$1.22M
Total Assets
$11.01M
Current Assets
$5.17M
Working Capital
$1.67M

Ownership

Promoter Holding
32.96%
Chg in Prom Hold
-
FII / Inst Holding
10.19%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$215.04K
EBITDA
$-20.18M
Free Cash Flow
$-16.22M
Operating Cash Flow
$-14.33M
Shares Outstanding
17.14M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ------------168.55K133.69K162.09K3.00K8.00K5.00K1.00K3.00K16.00K3.00K32.76K014.60K19.00K273.23K1.03M922.72K801.46K49.86K12.29K315.28K36.82K81.49K543.10K594.97K760.42K-1.68M551.15K
Cost of Revenue -----------------------------------404.82K871.33K547.78K742.49K202.74K
Gross Profit 109.42K128.61K40.15K125.97K73.40K------------------014.60K19.00K25.25K128.02K110.33K81.31K4.61K-166.39K-302.02K-6.72K39.09K138.28K-276.37K212.63K-2.43M348.41K
Operating Expenses -----------------------------------3.92M4.36M4.57M5.94M4.95M
Operating Income -157.82K-46.30K-264.76K-87.03K-110.23K-39.55K-73.50K17.36K-3.38K19.77K-144.25K65.15K65.36K9.68K56.41K-550.35K-110.93K-90.86K-82.21K-161.56K-80.02K-2.19K23.77K-66.55K-1.87M-552.39K-873.71K-1.21M-912.99K-1.68M-1.77M-1.88M-2.20M-3.02M-2.74M-3.79M-4.64M-4.36M-8.36M-4.60M
EBITDA ------------------------------------3.53M-4.45M-4.16M-7.94M-4.35M
Interest Expense -----------------------------------0---13.06K
Pretax Income ------------------------------------3.70M-4.58M-4.35M-8.35M-4.57M
Tax Provision -----------------------------------00000
Net Income -175.84K-119.97K-285.95K-129.40K-143.05K-53.33K---18.07K--55.21K--56.62K-549.64K-110.93K-95.15K-160.84K-170.82K-709-18673.77K-66.55K-1.87M-551.96K-872.86K-1.21M-912.83K-1.64M-1.65M-1.73M-2.02M-2.93M-2.70M-3.70M-4.58M-4.35M-8.35M-4.57M
Diluted EPS ---------------------------------0.02-0.020.02-0.30-0.30-0.30--0.26
R&D Expense 77.41K67.50K151.48K111.11K45.78K84.66K56.32K51.85K57.73K46.73K177.88K47.66K46.73K78.37K35.29K489.42K71.42K35.06K34.62K114.62K34.94K01.74K29.18K124.67K115.94K185.65K422.69K118.25K355.90K271.96K317.57K535.15K566.57K424.58K533.59K531.17K755.94K-449.83K

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue --33.84K193.39K193.69K359.36K428.75K529.86K587.61K852.44K190.09K24.00K86.57K-3.02M743.95K445.44K215.04K
Cost of Revenue --------------2.68M1.85M1.36M2.57M
Gross Profit --33.84K56.47K193.69K359.36K428.75K529.68K------336.50K-1.11M-912.71K-2.35M
Operating Expenses --------------5.09M7.53M11.89M18.80M
Operating Income ---334.72K-2.57M-4.74M-944.55K-437.05K-370.31K-61.49K431.33K-680.00K-412.43K-11.66K--4.76M-8.64M-12.80M-21.15M
EBITDA ---------------4.69M-8.56M-12.21M-20.18M
Interest Expense ----------------041.21K
Pretax Income ---------------4.69M-8.10M-12.43M-20.98M
Tax Provision --------------0000
Net Income -829.56K-890.98K-308.35K-2.55M-4.76M-1.05M-565.91K-426.63K-123.76K404.35K-679.08K-514.92K40.34K--4.69M-8.10M-12.43M-20.98M
Diluted EPS ---------------0.40-0.60-0.90-1.38
R&D Expense --169.66K994.62K1.32M459.65K364.10K627.89K331.04K210.62K630.74K218.92K57.72K375.03K1.11M1.50M2.14M2.52M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets ---33.03K66.52K711.75K466.01K327.82K302.68K363.17K508.76K104.16K37.49K103.81K-9.92M16.12M19.18M11.41M
Current Assets ---------------8.72M14.90M14.89M5.85M
Cash & Equivalents --20.46K15.65K7.53K45.28K48.31K4.74K5.60K4.79K1.34K8.48K20.03K95.39K-4.05M10.45M10.65M3.20M
Inventory ---------------1.66M2.28M1.70M1.47M
Receivables ---------------064.79K269.73K668.90K
Total Liabilities ---153.89K360.29K532.95K521.68K516.14K527.63K504.07K245.31K39.14K407.38K92.56K-1.66M1.37M3.71M4.68M
Current Liabilities ---153.89K179.30K280.33K521.68K141.91K527.63K504.07K245.31K39.14K101.13K92.56K-1.66M1.37M3.13M4.18M
Long Term Debt ------------306.25K-----34.88K
Total Debt ----------------0652.70K1.22M
Total Equity 405.20K-329.04K-109.51K-120.86K-293.78K178.80K-55.67K-188.32K-224.95K-140.90K263.45K65.02K-35.74K11.25K-8.25M14.75M15.47M6.72M
Shares Outstanding ---------------12.67M13.27M14.43M17.14M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -298.27K-1.47M-1.04M-314.26K-337.48K-38.87K-146.75K271.55K157.15K-287.45K64.76K--4.95M-9.03M-10.59M-14.33M
Investing Cash Flow -3.54K-11.19K--57.72K-13.59K-16.12K-----275--2.16M1.85M-653.54K-1.90M
Financing Cash Flow 297.00K1.47M1.08M375.00K307.50K55.85K-147.57K-275.00K-150.00K299.00K2.05K-25.05K13.58M11.45M8.77M
Capital Expenditure -3.54K-11.19K-57.72K-13.59K------0--196.86K-111.72K-653.54K-1.90M
Free Cash Flow -301.81K-1.48M--256.54K-351.07K-----64.76K--5.15M-9.15M-11.24M-16.22M
Net Change in Cash -------------7.08M6.40M206.24K-7.45M
Share Buybacks ---320.38K-------300.00K-----

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --100.0%29.2%100.0%100.0%100.0%100.0%------11.2%-149.0%-204.9%-1,093.5%
Operating Margin % ---989.1%-1,327.3%-2,449.3%-262.8%-101.9%-69.9%-10.5%50.6%-357.7%-1,718.5%-13.5%--157.7%-1,161.8%-2,874.3%-9,834.2%
Net Margin % ---911.2%-1,320.4%-2,455.0%-293.6%-132.0%-80.5%-21.1%47.4%-357.2%-2,145.5%46.6%--155.5%-1,089.3%-2,791.4%-9,754.2%
ROE % 252.1%813.6%255.1%869.2%-2,659.4%1,895.0%300.5%189.7%87.8%153.5%-1,044.3%1,440.6%358.6%--56.8%-54.9%-80.4%-311.9%
ROCE % --276.9%2,275.8%-1,099.7%1,696.7%-235.1%164.6%43.6%163.7%-1,045.8%648.1%-103.7%--57.6%-58.6%-79.7%-292.8%

Shareholding Pattern

Insiders
32.96%
Institutions
10.19%
Public Float
15.20%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SCWO

Yahoo Finance hu, 30 Jul 2026

374Water highlights role of advanced wastewater treatment amid US foodborne illness investigation

374Water Inc (NASDAQ:SCWO, FRA:8LL) has highlighted the role it believes advanced wastewater treatment technologies can play in protecting public health as US officials investigate one of the largest foodborne illness outbreaks in recent hi…

Yahoo Finance hu, 30 Jul 2026

374Water Highlights Its Supercritical Water Oxidation Technology - AirSCWO - for PFAS and Pathogen Destruction, Wastewater Treatment, and Healthier Water Infrastructure

Company Highlights How AirSCWO™ Permanently Destroys Organic Contaminants-including PFAS "Forever Chemicals," Pathogens such as Cyclospora, Pharmaceuticals, Biosolids, and Industrial Waste-to Support Cleaner Water, Wastewater Reuse, and Hea…

Yahoo Finance hu, 30 Jul 2026

Nasdaq posts best day in weeks as Microsoft leads tech charge with Apple due

US inflation softened last month, with core PCE prices up 0.1% month-on-month in June

Yahoo Finance ue, 28 Jul 2026

374Water completes Phase 2 of Minnesota AirSCWO pilot, begins next testing stage

374Water Inc (NASDAQ:SCWO, FRA:8LL) announced that it has completed Phase 2 of its mobile AirSCWO deployment in St. Cloud, Minnesota, and has begun the third phase of the project as the state continues evaluating the company's technology fo…

Yahoo Finance ue, 28 Jul 2026

374Water's Mobile AirSCWO System Completes Phase 2 of the St. Cloud, MN Mobile AirSCWO Deployment; Begins Phase 3

Successful Class A biosolids campaign advances the State of Minnesota's evaluation of AirSCWO for permanent PFAS destruction MORRISVILLE, NC / ACCESS Newswire / July 28, 2026 / 374Water Inc. (NASDAQ:SCWO) ("374Water" or the "Company"), a le…

Yahoo Finance hu, 23 Jul 2026

374Water says US Army report validates AirSCWO technology for PFAS destruction

374Water Inc (NASDAQ:SCWO, FRA:8LL) announced that a newly released US Army Corps of Engineers technical report independently validated its AirSCWO technology, documenting a 99.9993% destruction and removal efficiency for PFAS in aqueous fi…

SCWO — Frequently Asked Questions

What is the current share price of SCWO?

As of 2026-08-05 17:25 PDT, SCWO trades at $2.26 on NASDAQ/NYSE. Its 52-week range is $1.76 to $7.00.

What is the market capitalisation of SCWO?

SCWO has a market capitalisation of $38.74M on NASDAQ/NYSE.

What is the P/E ratio of SCWO?

SCWO trades at a trailing price-to-earnings (P/E) ratio of -1.64. Its price-to-book (P/B) ratio is 5.76.

Is SCWO a good stock to buy?

This page provides a data-driven analysis of SCWO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space